Salim Ivomas Pratama Tbk (SIMP)
Indonesia Stock Exchange · Indonesia · prices in IDR · close of 27 Oct 2026
Key indicators
| Last close | IDR 520.00 |
|---|---|
| 52-week range | 456.00 – 930.00 |
| Return, 1 month / 3 months | −9.6% / −9.6% |
| Return, 1 year / 3 years | −11.1% / +53.1% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 43.2% |
| Worst drawdown (1 year) | -46.7% |
| Average daily value traded | 6,534.61M IDR |
| Dividend yield | 5.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Salim Ivomas Pratama is an Indonesian agribusiness company based in Jakarta. It grows oil palms and processes the fruit into crude palm oil and palm kernel, and it refines these into cooking oil and other edible oil products sold to households and food businesses. The company also runs plantations of other crops and supplies packaged consumer oils under its own brands, serving customers across Indonesia and in export markets.
On this site Salim Ivomas Pratama Tbk appears as a stock on the Indonesia Stock Exchange (Indonesia), code SIMP, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Salim Ivomas Pratama Tbk (SIMP) trades on the Indonesia Stock Exchange in Indonesia. It last closed at IDR 520.00 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 312 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.1% and over the last three months it fell 9.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Indonesia Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -11.2% | ||
| From 52-week high | -41.6% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.6% | ||
| 6-month return | -35.3% | ||
| 12-month return, skipping the last month | -1.7% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 43.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.7% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 6,534.61M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | −9.6% |
| 3 months | −9.6% |
| 6 months | −35.3% |
| 1 year | −11.1% |
| 3 years | +53.1% |
| 5 years | +29.9% |
Signals
| 50-day / 200-day average | 585.80 / 585.45 |
|---|---|
| Golden / death cross (60 days) | Golden, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 23.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jul 2026 | IDR 26.0000 |
| 1 Jul 2025 | IDR 20.0000 |
| 8 Jul 2024 | IDR 10.0000 |
| 6 Jul 2023 | IDR 15.0000 |
| 4 Jul 2023 | IDR 100,000.0000 |
| 1 Aug 2022 | IDR 13.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Indonesia Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.